Solid-phase refolding of poly-lysine tagged fusion protein of hEGF and angiogenin

  • Park, Sang-Joong (Dept. of Chemical Engineering, Hanyang University) ;
  • Ryu, Kang (Dept. of Chemical Engineering, Hanyang University) ;
  • Chai, Young-Gyu (Dept. of Biochemistry & Molecular Biology, Hanyang University) ;
  • Kweon, Oh-Byung (Central R&D Center, Daewoong Pharmaceutical Co., Ltd.) ;
  • Park, Seung-Kook (Central R&D Center, Daewoong Pharmaceutical Co., Ltd.) ;
  • Lee, Eun-Kyu (Dept. of Chemical Engineering, Hanyang University)
  • Published : 2001.11.07

Abstract

A fusion protein, consisting of human epidermal growth factor as a recognition domain and human angiogenin as a toxin domain, can be used as a targeted therapeutic against breast cancer cells among others. The fusion protein was expressed as inclusion body in recombinant E. coli, and when the conventional, solution-phase refolding process was used the refolding yield was very low due to severe aggregation, probably due to the opposite surface charge due to vastly different pI values of each domain. Solid-phase refolding process exploiting ionic interactions between the solid matrix and the protein was tried, but the ionic binding yield was very low regardless of the resins and pH conditions used. To provide higher affinity toward the solid matrix, six lysine residues were tagged to the N -terminus of the hEGF domain When the cation exchange resins such as heparin- or CM-Sepharose were used as the matrix, the adsorption capacity increased 2.5-3 times and the subsequent refolding yield increased nearly IS times compared to the conventional process.

Keywords